Process View
The network for 'regulation of fibroblast proliferation' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
Any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| Trp53 | transformation related protein 53 | 1.000 | |
| Bcl2 | B-cell leukemia/lymphoma 2 | 0.977 | |
| Pten | phosphatase and tensin homolog | 0.971 | |
| Gli3 | GLI-Kruppel family member GLI3 | 0.942 | |
| Pbx1 | pre B-cell leukemia transcription factor 1 | 0.912 | |
| Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.877 | |
| Rara | retinoic acid receptor, alpha | 0.867 | |
| Fgfr2 | fibroblast growth factor receptor 2 | 0.812 | |
| Apc | adenomatosis polyposis coli | 0.763 | |
| Lepr | leptin receptor | 0.703 | |
| Egfr | epidermal growth factor receptor | 0.685 | |
| Bax | BCL2-associated X protein | 0.581 | |
| Pax3 | paired box gene 3 | 0.573 | |
| C1qa | complement component 1, q subcomponent, alpha polypeptide | 0.548 | |
| Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.543 | |
| Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.529 | |
| Rxra | retinoid X receptor alpha | 0.517 | |
| Smad3 | MAD homolog 3 (Drosophila) | 0.514 | |
| Prrx1 | paired related homeobox 1 | 0.510 | |
| Jun | Jun oncogene | 0.462 | |
| Vhl | von Hippel-Lindau tumor suppressor | 0.450 | |
| Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.446 | |
| Nos3 | nitric oxide synthase 3, endothelial cell | 0.438 | |
| Tgfb1 | transforming growth factor, beta 1 | 0.421 | |
| Csf1 | colony stimulating factor 1 (macrophage) | 0.400 | |
| C1qc | complement component 1, q subcomponent, C chain | 0.387 | |
| Skil | SKI-like | 0.375 | |
| Mapk8 | mitogen-activated protein kinase 8 | 0.364 | |
| Fgfr1 | fibroblast growth factor receptor 1 | 0.353 | |
| Shh | sonic hedgehog | 0.337 | |
| Kit | kit oncogene | 0.298 | |
| Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.298 | |
| Fos | FBJ osteosarcoma oncogene | 0.277 | |
| Mcl1 | myeloid cell leukemia sequence 1 | 0.273 | |
| Trp63 | transformation related protein 63 | 0.272 | |
| Nfkb2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | 0.261 | |
| Btg2 | B-cell translocation gene 2, anti-proliferative | 0.254 | |
| Maff | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) | 0.250 | |
| Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.247 | |
| Apoe | apolipoprotein E | 0.246 | |
| Ccnd1 | cyclin D1 | 0.243 | |
| Sox10 | SRY-box containing gene 10 | 0.235 | |
| Hoxa9 | homeobox A9 | 0.231 | |
| Sirt1 | sirtuin 1 (silent mating type information regulation 2, homolog) 1 (S. cerevisiae) | 0.231 | |
| Polr2a | polymerase (RNA) II (DNA directed) polypeptide A | 0.228 | |
| Ret | ret proto-oncogene | 0.228 | |
| Ccnd2 | cyclin D2 | 0.227 | |
| Egr1 | early growth response 1 | 0.226 | |
| Stat3 | signal transducer and activator of transcription 3 | 0.219 | |
| Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.218 | |
| Ppargc1a | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | 0.215 | |
| Notch2 | Notch gene homolog 2 (Drosophila) | 0.215 | |
| Sox9 | SRY-box containing gene 9 | 0.190 | |
| Zfp36 | zinc finger protein 36 | 0.189 | |
| Nkx2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.176 | |
| Spry4 | sprouty homolog 4 (Drosophila) | 0.170 | |
| Rb1 | retinoblastoma 1 | 0.168 | |
| Gadd45b | growth arrest and DNA-damage-inducible 45 beta | 0.165 | |
| Mdm2 | transformed mouse 3T3 cell double minute 2 | 0.161 | |
| Pdgfrb | platelet derived growth factor receptor, beta polypeptide | 0.161 | |
| Esr1 | estrogen receptor 1 (alpha) | 0.160 | |
| Atf3 | activating transcription factor 3 | 0.159 | |
| Ntf3 | neurotrophin 3 | 0.157 | |
| Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.155 | |
| Mdm4 | transformed mouse 3T3 cell double minute 4 | 0.152 | |
| Gli2 | GLI-Kruppel family member GLI2 | 0.152 | |
| Nrg1 | neuregulin 1 | 0.149 | |
| Vdr | vitamin D receptor | 0.148 | |
| Bmp4 | bone morphogenetic protein 4 | 0.148 | |
| Erbb3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.146 | |
| Lep | leptin | 0.143 | |
| Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.142 | |
| Tcf21 | transcription factor 21 | 0.142 | |
| Myc | myelocytomatosis oncogene | 0.140 | |
| Fgf8 | fibroblast growth factor 8 | 0.138 | |
| Klf4 | Kruppel-like factor 4 (gut) | 0.137 | |
| Gdf1 | growth differentiation factor 1 | 0.136 | |
| Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.134 | |
| Wnt5a | wingless-related MMTV integration site 5A | 0.131 | |
| Adamts1 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 | 0.130 | |
| Acvr1 | activin A receptor, type 1 | 0.129 | |
| Vegfa | vascular endothelial growth factor A | 0.127 | |
| Bak1 | BCL2-antagonist/killer 1 | 0.127 | |
| Lif | leukemia inhibitory factor | 0.125 | |
| Thbs1 | thrombospondin 1 | 0.120 | |
| Lmna | lamin A | 0.116 | |
| Pdgfra | platelet derived growth factor receptor, alpha polypeptide | 0.112 | |
| Pax6 | paired box gene 6 | 0.110 | |
| Pvr | poliovirus receptor | 0.108 | |
| Mark4 | MAP/microtubule affinity-regulating kinase 4 | 0.108 | |
| Cbl | Casitas B-lineage lymphoma | 0.104 | |
| C1qb | complement component 1, q subcomponent, beta polypeptide | 0.102 | |
| Nodal | nodal | 0.100 | |
| Cdk1 | cyclin-dependent kinase 1 | 0.099 | |
| Nfe2l2 | nuclear factor, erythroid derived 2, like 2 | 0.097 | |
| Fgf10 | fibroblast growth factor 10 | 0.095 | |
| Ednrb | endothelin receptor type B | 0.095 | |
| Hbegf | heparin-binding EGF-like growth factor | 0.094 | |
| Lyz2 | lysozyme 2 | 0.094 | |
| Egr2 | early growth response 2 | 0.094 |
| Name | Description | Probability | Func Analog Organism |
|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.992 | |
| CDK2 | cyclin-dependent kinase 2 | 0.972 | |
| RING1 | ring finger protein 1 | 0.942 | |
| RB1 | retinoblastoma 1 | 0.932 | |
| E2F1 | E2F transcription factor 1 | 0.895 | |
| NAMPT | nicotinamide phosphoribosyltransferase | 0.694 | |
| VEGFA | vascular endothelial growth factor A | 0.589 | |
| AXL | AXL receptor tyrosine kinase | 0.475 | |
| RNF2 | ring finger protein 2 | 0.453 | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.424 | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.346 | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.312 | |
| RBL2 | retinoblastoma-like 2 (p130) | 0.286 | |
| TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 0.281 | |
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.276 | |
| APLF | aprataxin and PNKP like factor | 0.270 | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.263 | |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.256 | |
| TFDP1 | transcription factor Dp-1 | 0.247 | |
| DTX3L | deltex 3-like (Drosophila) | 0.237 | |
| CCNE1 | cyclin E1 | 0.232 | |
| CBX8 | chromobox homolog 8 | 0.223 | |
| CCND1 | cyclin D1 | 0.222 | |
| NRP1 | neuropilin 1 | 0.193 | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.187 | |
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.184 | |
| CDK6 | cyclin-dependent kinase 6 | 0.155 | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.154 | |
| PARP14 | poly (ADP-ribose) polymerase family, member 14 | 0.151 | |
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.143 | |
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.140 | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.137 | |
| RBBP8 | retinoblastoma binding protein 8 | 0.130 | |
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.128 | |
| E2F4 | E2F transcription factor 4, p107/p130-binding | 0.125 | |
| IGF2R | insulin-like growth factor 2 receptor | 0.105 | |
| CKS1B | CDC28 protein kinase regulatory subunit 1B | 0.093 | |
| TP53 | tumor protein p53 | 0.090 | |
| CBX7 | chromobox homolog 7 | 0.085 | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.085 | |
| CBX6 | chromobox homolog 6 | 0.085 | |
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.083 | |
| PGF | placental growth factor | 0.081 | |
| PARP9 | poly (ADP-ribose) polymerase family, member 9 | 0.078 | |
| PLAUR | plasminogen activator, urokinase receptor | 0.071 | |
| BMI1 | BMI1 polycomb ring finger oncogene | 0.068 | |
| CCND2 | cyclin D2 | 0.068 | |
| EGFR | epidermal growth factor receptor | 0.067 | |
| MAX | MYC associated factor X | 0.065 | |
| LIN9 | lin-9 homolog (C. elegans) | 0.059 | |
| CCND3 | cyclin D3 | 0.056 | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.054 | |
| TFF1 | trefoil factor 1 | 0.053 | |
| LIG4 | ligase IV, DNA, ATP-dependent | 0.051 | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.048 | |
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.047 | |
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.046 | |
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.046 | |
| RYBP | RING1 and YY1 binding protein | 0.045 | |
| PLAT | plasminogen activator, tissue | 0.043 | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.042 | |
| RBL1 | retinoblastoma-like 1 (p107) | 0.042 | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.041 | |
| ALDOA | aldolase A, fructose-bisphosphate | 0.040 | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.039 | |
| KLF6 | Kruppel-like factor 6 | 0.039 | |
| CCNA2 | cyclin A2 | 0.039 | |
| LGALS8 | lectin, galactoside-binding, soluble, 8 | 0.038 | |
| ENO1 | enolase 1, (alpha) | 0.038 | |
| LIN54 | lin-54 homolog (C. elegans) | 0.037 | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.037 | |
| PLAU | plasminogen activator, urokinase | 0.036 | |
| SKIL | SKI-like oncogene | 0.036 | |
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.035 | |
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.035 | |
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.035 | |
| RXRA | retinoid X receptor, alpha | 0.032 | |
| JUNB | jun B proto-oncogene | 0.031 | |
| KRT5 | keratin 5 | 0.030 | |
| PNKP | polynucleotide kinase 3'-phosphatase | 0.030 | |
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.030 | |
| FZD1 | frizzled homolog 1 (Drosophila) | 0.030 | |
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.028 | |
| E2F3 | E2F transcription factor 3 | 0.028 | |
| PGK1 | phosphoglycerate kinase 1 | 0.028 | |
| CTSB | cathepsin B | 0.028 | |
| BCL3 | B-cell CLL/lymphoma 3 | 0.027 | |
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.027 | |
| RNF144B | ring finger protein 144B | 0.027 | |
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.027 | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.026 | |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.026 | |
| CDK4 | cyclin-dependent kinase 4 | 0.026 | |
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.026 | |
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.026 | |
| COL11A2 | collagen, type XI, alpha 2 | 0.026 | |
| E2F6 | E2F transcription factor 6 | 0.025 | |
| SIRT1 | sirtuin 1 | 0.024 | |
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.024 | |
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.024 |